COLL - Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc. (COLL) is a specialized pharmaceutical firm dedicated to the development and marketing of medications for pain management. Its diverse product lineup features significant therapies aimed at addressing various pain conditions.
As of Jun 30, 2026: spot at $36.03, ATM IV 58.9%, max pain $30.00, net GEX -$1.9K.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.19B
- P/E Ratio
- 15.67
- Beta
- 0.75
- 52-Week Range
- 29.19-50.787
- CEO
- Vikram Karnani
- Employees
- 357
- IPO Date
- May 7, 2015
- Exchange
- NASDAQ
What COLL Looks Like to Options Traders Today
IV rank of 13.4% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); negative net gamma exposure (-$1.9K) means dealers hedge with trend, amplifying realized volatility and accelerating directional moves; the 25-delta skew (0.017) is roughly flat across the wings.
What This Page Covers
The COLL overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked COLL overview questions
- What is COLL?
- COLL is the ticker symbol for Collegium Pharmaceutical, Inc., a listed security. Collegium Pharmaceutical, Inc. (COLL) is a specialized pharmaceutical firm dedicated to the development and marketing of medications for pain management. Listed on NASDAQ. COLL is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the COLL options snapshot look like today?
- As of Jun 30, 2026, the COLL options snapshot shows spot at $36.03, ATM IV 58.9%, IV rank 13.4%, max pain $30.00, net GEX -$1.9K, expected move 16.89%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are COLL's key statistics?
- Collegium Pharmaceutical, Inc. (COLL) carries a market capitalization of $1.19B, trailing P/E ratio of 15.67, beta of 0.75 relative to the broader market, 52-week range of 29.19-50.787. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does COLL belong to?
- Collegium Pharmaceutical, Inc. operates in the Healthcare sector, in the Drug Manufacturers - Specialty & Generic industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare COLL's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the COLL data on this page?
- The options snapshot above is dated Jun 30, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).